Elevated IgM against Nε-(Carboxyethyl)lysine-modified Apolipoprotein A1 peptide 141–147 in Taiwanese with Alzheimer's disease - Bioinformatics Solutions Inc

Elevated IgM against Nε-(Carboxyethyl)lysine-modified Apolipoprotein A1 peptide 141–147 in Taiwanese with Alzheimer’s disease

On 2018-04-202018-04-24By Bioinformatics Solutions IncIn User Publications

Lin, C.Y., et al. Elevated IgM against Nε-(Carboxyethyl)lysine-modified Apolipoprotein A1 peptide 141–147 in Taiwanese with Alzheimer’s disease. Clinical Biochemistry. 20/4/2018.